Skip to Content

Research & Funding

Current Other NCI & NIH InitiativesRSS

This page lists current other NCI and NIH cancer imaging initiatives, including grant mechanisms where industry is encouraged to apply.

For information about the funding process, go to Mechanisms or Guidelines.

The NCI's Division of Extramural Activities provides information about newly approved concepts, which may become RFAs and PAs. Check the Concepts Cleared at the NCI Board of Scientific Advisors Meeting web site for the earliest possible information about future initiatives.

  • PAR-16-089: Imaging and Biomarkers for Early Detection of Aggressive Cancer (U01)

    Source: FOA Page

    • Release Date: January 28, 2016
    • Application Receipt Date: Jul 11, 2016; Dec 14, 2016; Jul 10, 2017; Dec 11, 2017; Jul 10, 2018; Dec 11, 2018
    • Expiration Date: Dec 12, 2018
    • Contacts:

      Scientific contacts:
      Richard Mazurchuk, Ph.D. (NCI), Phone: 240-276-7126, Email: Richard.Mazurchuk@nih.gov
      Keyvan Farahani, Ph.D. (NCI), Phone: 240-276-5821, Email: farahank@mail.nih.gov

    The purpose of this Funding Opportunity Announcement (FOA) is to: (i) invite researchers to submit collaborative research project (U01) applications to improve cancer screening, early detection of aggressive cancer, assessment of cancer risk and cancer diagnosis aimed at integrating multi-modality imaging strategies and multiplexed biomarker methodologies into a singular complementary approach, and (ii) establish a Consortium for Imaging and Biomarkers (CIB) to perform collaborative studies, exchange information, share knowledge and leverage common resources. The research will be conducted by individual multi-disciplinary research teams, hereafter called Units. All Units are expected to participate in collaborative activities with other Units within the Consortium.

  • PAR-15-334: Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)

    Source: FOA Page

    • Release Date: January 28, 2016
    • Application Receipt Date: Nov 20, 2015; Jun 14, 2016; Nov 21, 2016; Jun 14, 2017; Nov 20, 2017; Jun 14, 2018
    • Expiration Date: Jun 15, 2018
    • Contacts:

      Juli Klemm, Ph.D., NCI, Phone: 301-480-5778, Email: juli.klemm@nih.gov

    The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant (R21) applications for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum, including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities.  As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative, this FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods that can considerably improve acquisition, management, analysis, and dissemination of relevant data and/or knowledge. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, the proposed informatics method or algorithm must have a clear rationale on why it is novel and how it will benefit the cancer research field. Potential applicants who are interested in more downstream tool development, from prototyping to hardening and adaptation, should consult the other companion FOAs listed above.

  • PAR-15-331: Advanced Development of Informatics Technologies for Cancer Research and Management (U24)

    Source: FOA page

    • Release Date: January 28, 2016
    • Application Receipt Date: Nov 20, 2015; Jun 14, 2016; Nov 21, 2016; Jun 14, 2017; Nov 20, 2017; Jun 14, 2018
    • Expiration Date: Jun 15, 2018
    • Contacts:

      Juli Klemm, Ph.D., NCI, Phone: 301-480-5778, Email: juli.klemm@nih.gov

    The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum, including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative, this FOA focuses on emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process should be included. Potential applicants who are interested in early-stage development or informatics resource sustainment should consult companion FOAs listed above.